Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study

Cancer - United States
doi 10.1002/cncr.31685
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase 2 and Biomarker Study of Cabozantinib in Patients With Advanced Cholangiocarcinoma

Cancer
Cancer ResearchOncology
2017English

Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers

Oncologist
Cancer ResearchMedicineOncology
2015English

Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Gastroenterology
Gastroenterology
2016English

Correction: Phase 2 Study of Pembrolizumab in Patients With Advanced Rare Cancers

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Phase I Clinical Trial Combining Imatinib Mesylate and IL-2

OncoImmunology
OncologyAllergyImmunology
2013English

Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial

The Lancet Oncology
Oncology
2012English

Correction 2: Everolimus (EVE) and Exemestane (EXE) in Patients With Advanced Breast Cancer Aged ≥ 65 Years: New Lessons for Clinical Practice From the EVA Study

Oncotarget
Oncology
2018English

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Neue Daten Zu Imatinib Und Everolimus

Uro-News
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy